期刊文献+

微创技术在不明原因胸腔积液诊断中的应用 被引量:2

Applicationof Minimally Invasive Technique in the Diagnosis of Pleural Effusion of Unknown Origin
下载PDF
导出
摘要 目的:探讨微创技术在不明原因胸腔积液诊断中的应用。方法:选取胸腔积液患者216例的临床资料。其中,结核性胸腔积液106例,恶性胸腔积液110例。均行改良胸膜活体组织检查(活检)术检查,胸水细胞学检查,胸水ADA、CEA及LDH检测以及血CEA检测。比较检测结果。结果:首次穿刺取材成功205例,成功率94.9%,首次穿刺成功的胸膜活检材料病理结果显示有诊断价值的127份,占58.8%,总确诊率65.3%。恶性胸腔积液组胸水CEA、胸水LDH、血CEA以及胸水CEA/血CEA水平以及阳性率均显著高于结核胸水组;结核性胸腔积液组胸水ADA水平以及阳性率显著高于恶性胸腔积液组,差异均有统计学意义(P<0.01)。结论:临床上可联合多种指标明确胸腔积液病因,指导治疗。 Objective:To investigate the application of minimally invasive technique in the diagnosis of pleural effusion of unknown origin.Methods:Clinical data of 216 patients with pleural effusion.Of which 106 cases of tuberculous pleural effusion,malignant pleural effusion in 110 cases.underwent modified pleural biopsy,pleural fluid cytology,pleural fluid ADA,CEA and LDH detection and blood CEA detection.Comparison of test results.Results:The success rate of the first puncture was 94.9%.The biopsy results of the first biopsy showed that there were 127 diagnoses,accounting for 58.8%and 65.3%respectively.The levels of pleural effusion CEA,pleural effusion LDH,CEA and CEA / blood CEA in pleural effusion were significantly higher than those in tuberculous pleural effusion group.The ADA level and positive rate of pleural effusion in tuberculous pleural effusion group were significantly higher than that in malignant pleural effusion Group,the difference was statistically significant(P〈0.01).Conclusion:A variety of clinical indicators can be combined with a clear cause of pleural effusion,guiding treatment.
出处 《中国医药导刊》 2017年第2期109-110,113,共3页 Chinese Journal of Medicinal Guide
基金 河北省2013年医学科学研究课题计划(编号:20130434) 课题名称:微创技术在不明原因胸腔积液诊断中的应用
关键词 改良胸膜活检术 生物标志物 细胞学检查 胸腔积液 Modified pleural biopsy Biomarkers Cytology Pleural effusion
  • 相关文献

参考文献10

二级参考文献106

  • 1社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3052
  • 2Piras M A, Gakis C, Budroni M. Adenosine deaminase activity in pleural effusion: an aid to differential diagnosis [ J ]. BM, 1978,2:1751 - 1752.
  • 3叶应抚,王毓三.全国临床检验操作规程[M].第二版.南京:东南大学出版社,1997.235-236.
  • 4吴聪,江静,谢作华,黄陆颖,梁象东,施焕中.腺苷脱氨酶对结核性胸膜炎诊断价值的荟萃分析[J].内科,2007,2(5):718-723. 被引量:9
  • 5Luyt CE, Guerin V, Combes A,et al. Proealcitonin kinetics as a prog- nostic marker of ventilator-associated pneumonia[J]. Am J Respir Crit Care Med,2005,171 (1) :48-53.
  • 6Cakir E, Deniz O, Ozean O, et al. Pleural fluid and serum procalcitonin as diagnostic tools in tuberculous pleurisy [ J ]. Clin Biochem, 2005,38 (3) :234-238.
  • 7Lin MC, Chen YC, Wu JT, et al. Diagnostic and prognostic values of pleural fluid procalcitonin in parapneumonic pleural effusions [ J ]. Chest,2009,136 ( 1 ) :205-211.
  • 8Molina R, Auge JM, Escudero JM, et al. Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as tumor markers in patients with lung canc- er: comparison with CYFRA 21-1, CEA, SCC and NSE[J]. Tumour Biol,2008,29 (6) : 371-380.
  • 9Jolobe OMP. Atypical tuberculous p|eural effusions [ J ]. European Journal of Internal Medicine,2011,22:456-459.
  • 10Jeon D. Tuberculous pleurisy: an update. Tubere Respir Dis (Seoul), 2014,76(4) : 153-159.

共引文献106

同被引文献8

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部